Bench-to-bedside translation of magnetic nanoparticles

Nanomedicine

Volumn 9, Issue 4, 2014, Pages 501-516

  Singh, Dhirender ^a   Mcmillan, JoEllyn M ^a   Kabanov, Alexander V ^b   Sokolsky Papkov, Marina ^b   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

biocompatibility; drug targeting; magnetic hyperthermia; MRI; nanoparticle; targeted drug and gene delivery; tissue engineering

Indexed keywords

FERUCARBOTRAN; MAGNETIC NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; MAGNETITE NANOPARTICLE;

BIOCOMPATIBILITY; BIOMAGNETISM; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HYPERTHERMIA; MAGNETIC SEPARATION; MAGNETOFECTION; NANOIMAGING; NANOMEDICINE; NANONEUROMEDICINE; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; ANIMAL; DIAGNOSTIC USE; HYPERTHERMIC THERAPY; MAGNETISM; PROCEDURES; TOXICITY; TRANSLATIONAL RESEARCH;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS; MAGNETITE NANOPARTICLES; NANOMEDICINE; TISSUE ENGINEERING; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84899880964     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.5     Document Type: Review

References (147)

1. Kumari A. Yadav SK. Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid. Surf.B. Biointerface 75 1 1-18 2010
2. Kim BY. Rutka JT. Chan WC. Nanomedicine.N. Engl.J. Med 363 25 2434-2443 2010
3. Veiseh O. Gunn JW. Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev 62 3 284-304 2010
4. Chertok B. Moffat BA. David AE. et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29 4 487-496 2008
5. Mahajan SD. Aalinkeel R. Law WC. et al. Anti-HIV-1 nanotherapeutics: Promises and challenges for the future. Int.J. Nanomed.7 5301-5314 2012
6. Colombo M. Carregal-Romero S. Casula MF. et al. Biological applications of magnetic nanoparticles. Chem. Soc. Rev 41 11 4306-4334 2012
7. Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev.112(11), 5818-5878 (2012
8. Krishnan KM. Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Transact. Magn.46(7), 2523-2558 (2010
9. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol.11(11), 2319-2331 (2001
10. Guo D, Li T, McMillan J et al. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution. Nanomedicine (Lond.) doi:10.2217/nnm.13.92 (2013) (Epub ahead of print
11. Banerjee R, Katsenovich Y, Lagos L, McIintosh M, Zhang X, Li CZ. Nanomedicine: Magnetic nanoparticles and their biomedical applications. Curr. Med. Chem.17(27), 3120-3141 (2010
12. Johannsen M, Gneveckow U, Eckelt L et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int.J. Hypertherm.21(7), 637-647 (2005
13. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int.J. Hypertherm.26(8), 790-795 (2010
14. Maier-Hauff K, Ulrich F, Nestler D et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.J. Neurooncol.103(2), 317-324 (2011
15. Lubbe AS, Bergemann C, Riess H et al. Clinical experiences with magnetic drug targeting: A phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res.56(20), 4686-4693 (1996
16. Choi HS, Liu W, Misra P et al. Renal clearance of quantum dots. Nat. Biotechnol.25(10), 1165-1170 (2007
17. Shubayev VI, Pisanic TR 2nd, Jin S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev.61(6), 467-477 (2009
18. Gratton SE, Ropp PA, Pohlhaus PD et al. The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105(33), 11613-11618 (2008
19. Chithrani BD, Ghazani AA, Chan WC Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett.6(4), 662-668 (2006
20. Chithrani BD, Chan WC Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett.7(6), 1542-1550 (2007
21. Huang X, Li L, Liu T et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 5(7), 5390-5399 (2011
22. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Ann. Rev. Biomed. Eng.14, 1-16 (2012
23. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharmaceut.5(4), 505-515 (2008
24. Lu AH, Salabas EL, Schuth F. Magnetic nanoparticles: Synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. Engl.46(8), 1222-1244 (2007
25. Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine (Lond.) 2(1), 23-39 (2007
26. Cui Y, Xu Q, Chow PK, Wang D, Wang CH. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials 34(33), 8511-8520 (2013
27. Gordon RT, Hines JR, Gordon D. Intracellular hyperthermia.A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med. Hypoth.5(1), 83-102 (1979
28. Wust P, Hildebrandt B, Sreenivasa G et al. Hyperthermia in combined treatment of cancer. Lancet Oncol.3(8), 487-497 (2002
29. Xu Y, Karmakar A, Heberlein WE, Mustafa T, Biris AR, Biris AS. Multifunctional magnetic nanoparticles for synergistic enhancement of cancer treatment by combinatorial radio frequency thermolysis and drug delivery. Adv. Healthcare Mat.1(4), 493-501 (2012
30. Owen J, Pankhurst Q, Stride E. Magnetic targeting and ultrasound mediated drug delivery: Benefits, limitations and combination. Int.J. Hypertherm.28(4), 362-373 (2012
31. Gonzales-Weimuller M, Zeisberger M, Krishnan KM. Size-dependant heating rates of iron oxide nanoparticles for magnetic fluid hyperthermia.J. Magn. Magn. Mater.321(13), 1947-1950 (2009
32. Purushotham S, Ramanujan RV. Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomat.6(2), 502-510 (2010
33. Shokrollahi H. Structure, synthetic methods, magnetic properties and biomedical applications of ferrofluids. Mat. Sci. Eng.C Mater. Biol. Appl.33(5), 2476-2487 (2013
34. Khandhar AP, Ferguson RM, Simon JA, Krishnan KM. Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia.J. Biomed. Mater. Res.A 100(3), 728-737 (2012
35. Ivkov R, DeNardo SJ, Daum W et al. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin. Cancer. Res.11(19 Pt 2), 7093s-7103s (2005
36. Kikumori T, Kobayashi T, Sawaki M, Imai T. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Br. Cancer Res. Treat.113(3), 435-441 (2009
37. Sadhukha T, Wiedmann TS, Panyam J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34(21), 5163-5171 (2013
38. Kawai N, Ito A, Nakahara Y et al. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 64(4), 373-381 (2005
39. Kubes J, Svoboda J, Rosina J, Starec M, Fiserova A. Immunological response in the mouse melanoma model after local hyperthermia. Physiol. Res.57(3), 459-465 (2008
40. Multhoff G. Hyperthermia classic commentary: Activation of natural killer (NK) cells by heat shock protein 70, Gabriele Multhoff, International Journal of Hyperthermia, 18, 576-585. Int.J. Hypertherm.25(3), 176-179 (2009) (2002
41. Qiao R, Yang C, Gao M. Superparamagnetic iron oxide nanoparticles: From preparations to in vivo MRI applications.J. Mater. Chem.19(35), 6274-6293 (2009
42. Hao R, Xing R, Xu Z, Hou Y, Gao S, Sun S. Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater.22(25), 2729-2742 (2010
43. Singamaneni S, Bliznyuk VN, Binek C, Tsymbal EY. Magnetic nanoparticles: Recent advances in synthesis, self-Assembly and applications.J. Mater. Chem.21(42), 16819-16845 (2011
44. Yoo D, Lee JH, Shin TH, Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res.44(10), 863-874 (2011
45. Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors.J. Cell Biol.188(6), 759-768 (2010
46. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev.53(2), 283-318 (2001
47. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov.2(3), 214-221 (2003
48. Wang C, Ding C, Kong M et al. Tumor-Targeting magnetic lipoplex delivery of short hairpin RNA suppresses IGF-1R overexpression of lung adenocarcinoma A549 cells in vitro and in vivo. Biochem. Biophy. Res. Comm.410(3), 537-542 (2011
49. Li J, Zheng L, Cai H et al. Polyethyleneimine-mediated synthesis of folic acid-Targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials 34(33), 8382-8392 (2013
50. Wadajkar AS, Menon JU, Tsai YS et al. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles. Biomaterials 34(14), 3618-3625 (2013
51. Wang L, Neoh KG, Kang ET, Shuter B, Wang SC. Biodegradable magnetic-fluorescent magnetite/poly(dl-lactic acid-co-Alpha,beta-malic acid) composite nanoparticles for stem cell labeling. Biomaterials 31(13), 3502-3511 (2010
52. Odintsov B, Chun JL, Berry SE. Whole body MRI and fluorescent microscopy for detection of stem cells labeled with superparamagnetic iron oxide (SPIO) nanoparticles and DiI following intramuscular and systemic delivery. Methods Mol. Biol.1052, 1-17 (2013
53. Ma Y, Tong S, Bao G, Gao C, Dai Z. Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy. Biomaterials 34(31), 7706-7714 (2013
54. Kim SM, Chae MK, Yim MS et al. Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. Biomaterials 34(33), 8114-8121 (2013
55. Zhu L, Wang D, Wei X et al. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.J. Control. Release 169(3), 228-238 (2013
56. Yang X, Grailer JJ, Rowland IJ et al. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano 4(11), 6805-6817 (2010
57. Bleul R, Thiermann R, Marten GU et al. Continuously manufactured magnetic polymersomes - A versatile tool (not only) for targeted cancer therapy. Nanoscale 5(23), 11385-11393 (2013
58. Colson YL, Grinstaff MW. Biologically responsive polymeric nanoparticles for drug delivery. Adv. Mater.24(28), 3878-3886 (2012
59. Kirthivasan B, Singh D, Bommana MM, Raut SL, Squillante E, Sadoqi M. Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system. Nanotechnology 23(25), 255102 (2012
60. Meyers PH, Cronic F, Nice CM Jr. Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent. Am.J. Roentgenol. Radium Ther. Nucl. Med.90, 1068-1077 (1963
61. Widder KJ, Senyei AE, Ranney DF. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Adv. Pharmacol. Chemother.16, 213-271 (1979
62. Li D, Zhang YT, Yu M, Guo J, Chaudhary D, Wang CC. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles. Biomaterials 34(32), 7913-7922 (2013
63. Rudzka K, Viota JL, Munoz-Gamez JA, Carazo A, Ruiz-Extremera A, Delgado AV. Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticles. Colloid. Surf.B. Biointerface 111C, 88-96 (2013
64. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 29(29), 4012-4021 (2008
65. Corem-Salkmon E, Ram Z, Daniels D et al. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int.J. Nanomed.6, 1595-1602 (2011
66. Kempe H, Kempe M. The use of magnetite nanoparticles for implant-Assisted magnetic drug targeting in thrombolytic therapy. Biomaterials 31(36), 9499-9510 (2010
67. Licciardi M, Scialabba C, Cavallaro G, Sangregorio C, Fantechi E, Giammona G. Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticles.J. Biomed. Nanotechnol.9(6), 949-964 (2013
68. Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D. Thermal and pH responsive polymer-Tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. ACS Appl. Mater. Interface 5(9), 3884-3893 (2013
69. Shen JM, Gao FY, Yin T et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. Pharmacol. Res.70(1), 102-115 (2013
70. Thomsen LB, Linemann T, Pondman KM et al. Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem. Neurosci.4(10), 1352-1360 (2013
71. Yan F, Wang Y, He S, Ku S, Gu W, Ye L. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier.J. Mater. Sci. Mater. Med.24(10), 2371-2379 (2013
72. Fan CH, Ting CY, Lin HJ et al. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-Tumor drug delivery. Biomaterials 34(14), 3706-3715 (2013
73. Nair M, Guduru R, Liang P, Hong J, Sagar V, Khizroev S. Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers. Nat. Commun.4, 1707 (2013
74. Davis ME. Non-viral gene delivery systems. Curr. Opin. Biotechnol.13(2), 128-131 (2002
75. Guo X, Huang L. Recent advances in nonviral vectors for gene delivery. Acc. Chem. Res.45(7), 971-979 (2012
76. Miele E, Spinelli GP, Miele E et al. Nanoparticle-based delivery of small interfering RNA: Challenges for cancer therapy. Int.J. Nanomed.7, 3637-3657 (2012
77. Yang J, Hendricks W, Liu G et al.A nanoparticle formulation that selectively transfects metastatic tumors in mice. Proc. Natl Acad. Sci. USA 110(36), 14717-14722 (2013
78. Plank C, Zelphati O, Mykhaylyk O. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects. Adv. Drug Deliv. Rev.63(14-15), 1300-1331 (2011
79. Schwerdt JI, Goya GF, Calatayud MP, Herenu CB, Reggiani PC, Goya RG. Magnetic field-Assisted gene delivery: Achievements and therapeutic potential. Curr. Gene Ther.12(2), 116-126 (2012
80. Jiang S, Eltoukhy AA, Love KT, Langer R, Anderson DG Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett.13(3), 1059-1064 (2013
81. Wen M, Li B, Ouyang Y, Luo Y, Li S. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: A preliminary study. Ann. Biomed. Eng.37(6), 1240-1250 (2009
82. Prosen L, Prijic S, Music B, Lavrencak J, Cemazar M, Sersa G. Magnetofection: A reproducible method for gene delivery to melanoma cells. BioMed. Res. Int.2013, 209452 (2013
83. Kievit FM, Veiseh O, Bhattarai N et al. PEI-PEG-chitosan copolymer coated iron oxide nanoparticles for safe gene delivery: Synthesis, complexation, and transfection. Adv. Funct. Mater.19(14), 2244-2251 (2009
84. Morishita N, Nakagami H, Morishita R et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem. Biophy. Res. Comm.334(4), 1121-1126 (2005
85. Patnaik S, Gupta KC. Novel polyethylenimine-derived nanoparticles for in vivo gene delivery. Expert Opin. Drug Deliv.10(2), 215-228 (2013
86. Lee CH, Kim EY, Jeon K et al. Simple, efficient, and reproducible gene transfection of mouse embryonic stem cells by magnetofection. Stem Cell. Develop.17(1), 133-141 (2008
87. Fouriki A, Dobson J. Oscillating magnet array-based nanomagnetic gene transfection of human mesenchymal stem cells. Nanomedicine (Lond.) doi:10.2217/nnm.13.74 (2013) (Epub ahead of print
88. Adams CF, Pickard MR, Chari DM. Magnetic nanoparticle mediated transfection of neural stem cell suspension cultures is enhanced by applied oscillating magnetic fields. Nanomed. Nanotechnol. Biol. Med.9(6), 737-741 (2013
89. Earhart CM, Hughes CE, Gaster RS et al. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. Lab Chip 14(1), 78-88 (2014
90. Zhang L, Zhu X, Jiao D, Sun Y, Sun H. Efficient purification of His-Tagged protein by superparamagnetic Fe3O4/Au-ANTA-Co2+ nanoparticles. Mat. Sci. Eng.C Mater. Biol. Appl.33(4), 1989-1992 (2013
91. Intorasoot S, Srirung R, Intorasoot A, Ngamratanapaiboon S. Application of gelatin-coated magnetic particles for isolation of genomic DNA from bacterial cells. Analyt. Biochem.386(2), 291-292 (2009
92. Borlido L, Moura L, Azevedo AM, Roque AC, Aires-Barros MR, Farinha JP. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification. Biotechnol.J.8(6), 709-717 (2013
93. Whitesides GM, Kazlauskas RJ, Josephson L. Magnetic separations in biotechnology. Trends Biotechnol.1(5), 144-148 (1983
94. Gordon R, Hogan CE, Neal ML, Anantharam V, Kanthasamy AG, Kanthasamy A.A simple magnetic separation method for high-yield isolation of pure primary microglia.J. Neurosci. Method.194(2), 287-296 (2011
95. Harms AS, Tansey MG. Isolation of murine postnatal brain microglia for phenotypic characterization using magnetic cell separation technology. Methods Mol. Biol.1041, 33-39 (2013
96. Pimpha N, Chaleawlert-umpon S, Chruewkamlow N, Kasinrerk W. Preparation of anti-CD4 monoclonal antibody-conjugated magnetic poly(glycidyl methacrylate) particles and their application on CD4+ lymphocyte separation. Talanta 84(1), 89-97 (2011
97. Ditsch A, Yin J, Laibinis PE, Wang DIC, Hatton TA. Ion-exchange purification of proteins using magnetic nanoclusters. Biotechnol. Prog.22(4), 1153-1162 (2006
98. Lee KS, Lee IS. Decoration of superparamagnetic iron oxide nanoparticles with Ni2+: Agent to bind and separate histidine-Tagged proteins. Chem. Commun.(Camb.) 6, 709-711 (2008
99. Liu Z, Li M, Yang X, Yin M, Ren J, Qu X. The use of multifunctional magnetic mesoporous core/shell heteronanostructures in a biomolecule separation system. Biomaterials 32(21), 4683-4690 (2011
100. Benelmekki M, Xuriguera E, Caparros C et al. Design and characterization of Ni2+ and CO2+ decorated porous magnetic silica spheres synthesized by hydrothermal-Assisted modified-Stober method for His-Tagged proteins separation.J. Coll. Interface Sci.365(1), 156-162 (2012
101. Borlido L, Azevedo AM, Roque AC, Aires-Barros MR. Potential of boronic acid functionalized magnetic particles in the adsorption of human antibodies under mammalian cell culture conditions.J. Chromatogr.A 1218(43), 7821-7827 (2011
102. Borlido L, Azevedo AM, Sousa AG, Oliveira PH, Roque AC, Aires-Barros MR. Fishing human monoclonal antibodies from a CHO cell supernatant with boronic acid magnetic particles.J. Chromatogr.B 903, 163-170 (2012
103. Ito A, Kamihira M. Tissue engineering using magnetite nanoparticles. Prog. Mol. Biol. Translat. Sci.104, 355-395 (2011
104. Guillotin B, Guillemot F. Cell patterning technologies for organotypic tissue fabrication. Trends Biotechnol.29(4), 183-190 (2011
105. Sensenig R, Sapir Y, MacDonald C, Cohen S, Polyak B. Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine (Lond.) 7(9), 1425-1442 (2012
106. Yamamoto Y, Ito A, Kato M et al. Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering technique.J. Biosci. Bioeng.108(6), 538-543 (2009
107. Whatley BR, Li X, Zhang N, Wen X. Magnetic-directed patterning of cell spheroids.J. Biomed. Mater. Res.A (doi:10.1002/jbm.a.34797 2013) (Epub ahead of print
108. Ito A, Hayashida M, Honda H et al. Construction and harvest of multilayered keratinocyte sheets using magnetite nanoparticles and magnetic force. Tissue Eng.10(5-6), 873-880 (2004
109. Sato M, Ito A, Akiyama H, Kawabe Y, Kamihira M. Effects of B-cell lymphoma 2 gene transfer to myoblast cells on skeletal muscle tissue formation using magnetic force-based tissue engineering. Tissue Eng. Part A 19(1-2), 307-315 (2013
110. Kim JA, Choi JH, Kim M et al. High-Throughput generation of spheroids using magnetic nanoparticles for three-dimensional cell culture. Biomaterials 34(34), 8555-8563 (2013
111. Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2(1), 3-14 (2005
112. Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: A double-blind, placebo-controlled study in healthy volunteers. Clin. Exper. Allergy 32(1), 133-139 (2002
113. Blanchette M, Michaud K, Fortin D.A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.J. Neurosci. Method.207(2), 125-129 (2012
114. Pathirana W, Gunasekera SM, Constantine GR, Perera S, Perera BM, Kamaladiwela R. Brain targeted transcranial administration of diazepam and shortening of sleep latency in healthy human volunteers. Indian J. Pharmaceut. Sci.73(5), 497-503 (2011
115. Salahuddin TS, Johansson BB, Kalimo H, Olsson Y. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study. Acta Neuropathol.77(1), 5-13 (1988
116. Cornford EM, Young D, Paxton JW, Sofia RD. Blood-brain barrier penetration of felbamate. Epilepsia 33(5), 944-954 (1992
117. Peura L, Malmioja K, Huttunen K et al. Design, synthesis and brain uptake of LAT1-Targeted amino acid prodrugs of dopamine. Pharmaceut. Res.30(10), 2523-2537 (2013
118. Wu J, Yoon SH, Wu WM, Bodor N. Synthesis and biological evaluations of brain-Targeted chemical delivery systems of [Nva2]-TRH.J. Pharm. Pharmacol.54(7), 945-950 (2002
119. Pardridge WM, Boado RJ. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol.503, 269-292 (2012
120. Pardridge WM. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug. Chem.19(7), 1327-1338 (2008
121. Chen H, Tang L, Qin Y et al. Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. Eur.J. Pharma. Sci.40(2), 94-102 (2010
122. Teow HM, Zhou Z, Najlah M, Yusof SR, Abbott NJ, D'Emanuele A. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. Int.J. Pharmaceut.441(1-2), 701-711 (2013
123. Li J, Zhang C, Li J et al. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides. Pharmaceut. Res.30(7), 1813-1823 (2013
124. Jones SK, Rutherford KF, Ruys AJ, Gray BN. US patent application: Microparticles for selectively targeted hyperthermia. WO 2004064921 A1(PCT/AU2004/000089); issue date: 6 July (2006
125. Zhao M, Liang C, Li A et al. Magnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenografts. Anticancer Res.30(6), 2217-2223 (2010
126. Chertok B, David AE, Yang VC. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials 31(24), 6317-6324 (2010
127. Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: Effect of administration route and magnetic field topography.J. Control. Release 155(3), 393-399 (2011
128. Chang J, Jallouli Y, Kroubi M et al. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. Int.J. Pharmaceut.379(2), 285-292 (2009
129. Qiao R, Jia Q, Huwel S et al. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6(4), 3304-3310 (2012
130. Gandhi N, Saiyed ZM, Napuri J et al. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1-Associated neurocognitive disorder.J. Neurovirol.16(4), 294-305 (2010
131. Wang H, Zhang S, Liao Z et al. PEGlated magnetic polymeric liposome anchored with TAT for delivery of drugs across the blood-spinal cord barrier. Biomaterials 31(25), 6589-6596 (2010
132. Mejias R, Gutierrez L, Salas G et al. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications.J. Control. Release 171(2), 225-233 (2013
133. Li Y, Liu J, Zhong Y et al. Biocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo. Int.J. Nanomed.6, 2805-2819 (2011
134. Richards JM, Shaw CA, Lang NN et al. In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: Feasibility and safety in humans. Circ. Cardiovasc. Imag.5(4), 509-517 (2012
135. Ahamed M, Alhadlaq HA, Alam J, Khan MA, Ali D, Alarafi S. Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines. Curr. Pharmaceut. Design 19(37), 6681-6690 (2013
136. Ma P, Luo Q, Chen J et al. Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int.J. Nanomed.7, 4809-4818 (2012
137. Szalay B, Tatrai E, Nyiro G, Vezer T, Dura G. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments.J. Appl. Toxicol.32(6), 446-453 (2012
138. Iversen NK, Frische S, Thomsen K et al. Superparamagnetic iron oxide polyacrylic acid coated gamma-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol. Appl. Pharmacol.266(2), 276-288 (2013
139. Ke Y, Ming Qian Z. Iron misregulation in the brain: A primary cause of neurodegenerative disorders. Lancet Neurol.2(4), 246-253 (2003
140. Doraiswamy PM, Finefrock AE. Metals in our minds: Therapeutic implications for neurodegenerative disorders. Lancet Neurol.3(7), 431-434 (2004
141. Kim JE, Shin JY, Cho MH. Magnetic nanoparticles: An update of application for drug delivery and possible toxic effects. Arch. Toxicol.86(5), 685-700 (2012
142. Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res.62(2), 144-149 (2010
143. Zhang J, Shin MC, David AE et al. Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. Mol. Pharmaceut.10(10), 3892-3902 (2013
144. Lee JH, Jang JT, Choi JS et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat. Nanotechnol.6(7), 418-422 (2011
145. Wahajuddin, , Arora S. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers. Int.J. Nanomed.7, 3445-3471 (2012
146. Cansell F, Chevalier B, Demourgues A et al. Supercritical fluid processing: A new route for materials synthesis.J. Mater. Chem.9(1), 67-75 (1999
147. Kumagai M, Kano MR, Morishita Y. Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymer-coated magnetite nanoparticles with TGF-beta inhibitor.J. Control. Release 140(3), 306-311 (2009.